Company Overview
Snapshot
Founded in August 2013 by Amir Laniado and Michael Cohn, TillaCare operates with 11–50 employees. The company focuses on developing noninvasive solutions for urinary incontinence, a market it addressed with the introduction of its UriCap external urine collection device in November 2019.
Business overview
TillaCare specializes in developing noninvasive, leak-proof products for male and female urinary incontinence, along with complementary products designed to support active lifestyles. Its core products, UriCap-M and UriCap-F, aim to prevent invasive procedures like catheter placement, thereby reducing infection rates, bacterial resistance, and antibiotic-related side effects. The company's devices also enhance patient comfort by reducing moisture, decreasing sores in geriatric patients, and increasing mobility for those with urgency incontinence, ultimately improving quality of life. TillaCare operates within the Health Tech & Life Sciences sector, specifically targeting the medical devices market, and serves patients, seniors, and healthcare providers globally, including in the United States.
Strategic signal
In November 2019, TillaCare, in collaboration with AMT, introduced its UriCap external urine collection device. This launch signals the company's commitment to providing non-invasive solutions for urinary incontinence, addressing a critical need in patient care by aiming to reduce complications associated with traditional methods like catheterization. For investors, this highlights TillaCare's product development capabilities and its focus on improving patient outcomes and potentially reducing healthcare costs in the urology and geriatric care markets.
Log in to access full profile ›Company Intelligence Q&A
- What is TillaCare's primary focus?
- TillaCare specializes in providing noninvasive, leak-proof solutions for male and female urinary incontinence, aiming to enable active lifestyles and reduce complications associated with traditional methods.
- When was TillaCare founded and by whom?
- TillaCare was founded in August 2013 by Amir Laniado and Michael Cohn.
- What are TillaCare's main products?
- TillaCare's main products include UriCap-M and UriCap-F, which are designed to prevent invasive procedures like catheter placement, along with UriGuide.
- What problem do TillaCare's products address?
- TillaCare's products address the need for noninvasive urinary incontinence solutions, aiming to decrease infection rates, bacterial resistance, and antibiotic-related side effects, while improving patient comfort and mobility.
- When did TillaCare introduce its UriCap external urine collection device?
- In November 2019, TillaCare, in collaboration with AMT, introduced its UriCap external urine collection device.